Cellulite is a structural skin change that occurs in most post-pubertal females whether they are thin or overweight. It presents itself as a modification of skin morphology evident by skin dimpling and nodularity that occurs mainly in women on the pelvic region, lower limbs, and abdomen, and is caused by the herniation of subcutaneous fat within fibrous connective tissue, leading to a padded or orange peel-like appearance. Cellulite can occur in women of all ages and tends to become more visible with age. Over time, the skin loses its thickness and thereby enhances the visibility of the unsightly cellulite bumps.

All products pertaining to the Vela product line are FDA cleared (The Vela was the first system to be cleared by the FDA for Cellulite Reduction) and CE marked (Body Contouring) and all comply with the strict safety regulations presented by the European Directive of Medical Devices – ‘conformity with the provisions of the Council Directive 93/42/EEC of 14 June 1993 as amended by 2007/47/EC concerning medical devices’.

The Vela treatment can be applied to any body area that may need contouring: thighs, abdomen, arms, flanks and more. Wherever cellulite is bothersome for a patient, the Vela line of devices offers an effective solution to help solve the problem.

The Vela treatment is recommended for normal to overweight patients who suffer from unsightly cellulite in the pelvic region, around the hips, abdomen, or lower limbs. For optimized results, these patients should also be committed to maintaining a healthy lifestyle. The treating clinician has the final determination for choosing the best candidates for the treatment

There are no major contraindications for the Vela treatment. For patients with pacemakers/defibrillator, pregnant or nursing or severe health problems, it is recommended to defer to their physician prior to commencing treatment.

An improvement in the appearance of the skin can be observed in as few as 1-2 treatments. For optimal results, it is recommended to complete the recommended treatment protocol of 4-6 treatments. The treating clinician will determine the optimum number of treatments for the patient based on the patient’s areas of concern.